Development Level

Tbio 8 | 11,445

IMPC Phenotype

abnormal kidney morphology 1 | 65
abnormal lens morphology 1 | 81
cataract 1 | 92
increased circulating alkaline... 1 | 122

Disease

glioblastoma 6 | 5,792
Carcinoma 5 | 11,493
psoriasis 5 | 6,694
malignant mesothelioma 4 | 3,232
medulloblastoma, large-cell 4 | 6,241
osteosarcoma 4 | 7,950
ovarian cancer 4 | 8,520
pediatric high grade glioma 4 | 1,064
Autosomal recessive predisposition 3 | 1,442
atypical teratoid / rhabdoid tumor 3 | 5,112
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,955
lung cancer 3 | 4,740
lung carcinoma 3 | 2,843
pituitary cancer 3 | 1,972
Astrocytoma, Pilocytic 2 | 3,081
Cataract 2 | 297
Cognitive delay 2 | 608
Congenital disorder of glycosylation 2 | 54
Diarrhea 2 | 253
Galactosemia 2 | 19
Galactosemias 2 | 3
Galactosuria 2 | 4
Global developmental delay 2 | 608
Hypergalactosemia 2 | 3
Impairment of galactose metabolism 2 | 3
Lens Opacities 2 | 231
Mental and motor retardation 2 | 608
Muscle hypotonia 2 | 571
Neonatal Jaundice 2 | 30
adult high grade glioma 2 | 3,801
diabetes mellitus 2 | 1,728
ependymoma 2 | 4,679
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,291
lung adenocarcinoma 2 | 2,716
non-small cell lung cancer 2 | 2,890
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,962
Abnormal urinary amino-acid findings 1 | 38
Aminoaciduria 1 | 38
Anxiety 1 | 136
Anxiety disease 1 | 113
Big calvaria 1 | 147
Bilirubin metabolic disorder 1 | 41
Bleeding tendency 1 | 37
Blood Coagulation Disorders 1 | 42
Coagulation abnormalities 1 | 27
Coarse facial features 1 | 108
Congenital Disorder Of Glycosylation, Type IIID 1 | 1
Congenital disorder of glycosylation type 2D 1 | 1
Decreased liver function 1 | 24
Degenerative brain disorder 1 | 100
Delayed myelination 1 | 22
Diabetes Mellitus, Experimental 1 | 108
Dyspnea 1 | 76
Epileptic encephalopathy 1 | 26
Fatigue 1 | 182
Fatty liver disease 1 | 103
Generalized muscle weakness 1 | 57
Gout 1 | 106
Heart failure 1 | 162
Hemorrhagic Disorders 1 | 30
Hypoplasia of corpus callosum 1 | 90
Hypsarrhythmia 1 | 25
Icterus 1 | 82
Increased head circumference 1 | 147
Increased size of cranium 1 | 147
Increased size of skull 1 | 147
Liver Failure 1 | 73
Liver dysfunction, mild 1 | 24
Lymphoid leukemia 1 | 160
Metabolic acidosis 1 | 90
Mood swings 1 | 77
Myocardial Infarction 1 | 151
Nausea and vomiting 1 | 97
Nerve Degeneration 1 | 121
Neuro-degenerative disease 1 | 43
Neurodegenerative Disorders 1 | 79
Neurogenic Muscular Atrophy 1 | 139
Neurogenic muscle atrophy, especially in the lower limbs 1 | 139
Neutropenia 1 | 72
Open mouth 1 | 45
Osteoporosis 1 | 363
Ovarian dysfunction 1 | 18
Paralysed 1 | 42
Phenylketonuria 1 | 20
Premature Menopause 1 | 31
Premature ovarian failure 1 | 65
Primary hypogonadism 1 | 37
Prolonged neonatal jaundice 1 | 17
Recurrent infections 1 | 48
Respiratory Failure 1 | 104
Skeletal muscle atrophy 1 | 139
Supratentorial atrophy 1 | 94
Thickened facial skin with coarse facial features 1 | 108
Weight decreased 1 | 103
X-linked dominant 1 | 57
interstitial lung disease 1 | 298
muscle degeneration 1 | 139
posterior fossa group A ependymoma 1 | 468
tuberculosis and treatment for 6 months 1 | 409

Tissue

Blood and immune system 8 | 16,909
Cardiovascular System 8 | 15,192
Digestive Tract 8 | 17,369
Endocrine System 8 | 18,159
Female tissues 8 | 17,400
Liver and Pancreas 8 | 16,750
Male tissues 8 | 17,142
Nervous System 8 | 16,725
Respiratory system 8 | 16,393
Skin and soft tissues 8 | 17,230
Urinary Tract 8 | 16,678

Target Family

Enzyme 4 | 4,145
Kinase 2 | 634
Non-IDG 1 | 12,091
Transporter 1 | 473

GO Process

galactose metabolic process 8 | 8
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Beta-1,4-galactosyltransferase 1 B4GALT1 Tbio Enzyme -2.34454 211.1 130
Carbohydrate sulfotransferase 1 CHST1 Tbio Enzyme -1.02772 9.98 128
Galactokinase GALK1 Tbio Kinase -2.57441 372.4 197
Aldose 1-epimerase GALM Tbio Enzyme -1.84718 71.6 136
N-acetylgalactosamine kinase GALK2 Tbio Kinase -1.25867 17.2 203
Galactose-1-phosphate uridylyltransferase GALT Tbio Enzyme -2.34621 221.8 243
UDP-galactose translocator SLC35A2 Tbio Transporter -2.99582 934.5 32
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha PPARGC1A Tbio Non-IDG -2.86449 728.1 274